Trial intelligence / Profile preview

Yipanzhu granules for acute soft tissue injury

CTR20131967Phase 2Suspended

Sponsor
Wuhan Tonghua Technology Development
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of yipanzhu in musculoskeletal trauma, sponsored by Wuhan Tonghua Technology Development. Started May 2014; status: suspended.

02

Drugs

yipanzhu
03

Conditions

musculoskeletal trauma

Beyond the preview

Go deeper on CTR20131967.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131967.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call